Max Robotics — Global Service Robot Directory + US Certification

About

Dr. Zhaocheng Chi is a leading colorectal surgeon whose research focuses on advancing surgical techniques for middle and low rectal cancer, particularly through the comparison of robotic-assisted and laparoscopic approaches. His major contributions center on evaluating long-term oncological outcomes and the technical advantages of robotic surgery, especially in complex procedures like intersphincteric resection (ISR) and total mesorectal excision (TME). His most cited work, "Robotic vs Laparoscopic Surgery for Middle and Low Rectal Cancer" (2025, 79 citations), provides critical data on 3-year locoregional recurrence rates, addressing a key gap in evidence for robotic surgery’s efficacy. Additionally, his multicenter propensity score analysis of 1,571 patients (2024, 7 citations) demonstrates that robotic-assisted TME may reduce conversion rates and improve complete TME rates, with potential benefits for ISR. Dr. Chi’s study protocol for a multicenter randomized clinical trial (2024) further underscores his commitment to rigorous, evidence-based research. With a growing citation impact, his work is shaping clinical guidelines and offering surgeons and patients clearer insights into the comparative benefits of robotic versus laparoscopic techniques in rectal cancer treatment.